Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center.
about
Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cited rationale for variance i ...... emotherapy utilization center.
@en
Cited rationale for variance i ...... emotherapy utilization center.
@nl
type
label
Cited rationale for variance i ...... emotherapy utilization center.
@en
Cited rationale for variance i ...... emotherapy utilization center.
@nl
prefLabel
Cited rationale for variance i ...... emotherapy utilization center.
@en
Cited rationale for variance i ...... emotherapy utilization center.
@nl
P2093
P2860
P1433
P1476
Cited rationale for variance i ...... emotherapy utilization center.
@en
P2093
Brooke A Schlappe
Dennis S Chi
Ginger J Gardner
Jennifer J Mueller
Kara Long Roche
Oliver Zivanovic
Roisin E O'Cearbhaill
Yukio Sonoda
P2860
P356
10.1016/J.YGYNO.2016.05.015
P407
P577
2016-05-14T00:00:00Z